← Back to Search

Peer Support + Mobile App for HIV/AIDS (PATH Trial)

N/A

Recruiting

Research Sponsored by San Diego State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥18 years old

One or more detectable viral load test result (>200 copies m/L) in the past 12-months while on antiretroviral therapy for at least 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PATH Trial Summary

This trial is testing whether a combination of peer support and mobile technology can help improve HIV care outcomes for Hispanic and Black patients.

Who is the study for?

This trial is for Hispanic and Black adults living with HIV who are over 18, speak English or Spanish, on HIV medication, have internet access, and plan to stay in San Diego for the next year. They must have had treatment challenges like detectable viral loads while on therapy, missed appointments, infrequent care visits or low adherence to their antiretroviral regimen.Check my eligibility

What is being tested?

The PATH study is a randomized controlled trial testing an intervention that combines peer support with a mobile app designed to improve the management of HIV care among participants. It aims to see if this approach can help patients better adhere to treatments and maintain their health.See study design

What are the potential side effects?

Since this trial focuses on a non-medical intervention involving peer navigation and use of a mobile app, traditional side effects related to drugs are not applicable. However, there may be privacy concerns or emotional impacts from using the app.

PATH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have had a detectable viral load while on HIV medication for over 3 months.

Select...

I am currently taking medication for HIV.

Select...

I have been diagnosed with HIV by a doctor.

PATH Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Viral suppression

Secondary outcome measures

Antiretroviral therapy adherence

Gap in HIV medical visits

Retention in HIV care

PATH Trial Design

2Treatment groups

Active Control

Group I: Usual CareActive Control1 Intervention

Participants assigned to this group are in the control arm and will receive standard of care following the Ryan White model of care.

Group II: PATH Active Intervention ArmActive Control1 Intervention

Participants assigned to this group will receive care as usual if they are assigned to this group. In addition, participants in this arm will receive HIV care support from a trained peer navigator and have access to a mHealth web application designed to support their health and HIV care.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

San Diego State UniversityLead Sponsor

153 Previous Clinical Trials

83,958 Total Patients Enrolled

Media Library

PATH Clinical Trial Eligibility Overview. Trial Name: NCT05427318 — N/A

HIV/AIDS Research Study Groups: Usual Care, PATH Active Intervention Arm

HIV/AIDS Clinical Trial 2023: PATH Highlights & Side Effects. Trial Name: NCT05427318 — N/A

PATH 2023 Treatment Timeline for Medical Study. Trial Name: NCT05427318 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of enrolment for this research endeavor?

"Affirmative. Clinicaltrials.gov indicates that this clinical study, which was first made available on November 1st 2021, is actively enrolling participants. 375 patients need to be accepted from a single medical site."

Answered by AI

Are enrolment opportunities presently available for this research trial?

"Affirmative. Per the clinicaltrials.gov database, this medical trial is currently seeking participants and was first posted on November 1st 2021. This 375-person experiment has been edited most recently on June 16th 2022, with recruitment taking place at a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Peers Plus Mobile App for Treatment in HIV

Eileen Pitpitan 2021. "Peers Plus Mobile App for Treatment in HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05427318.